Reversing irreversible blindness

Glaucoma is the leading cause of irreversible blindness worldwide. By the time we reach the age of 80, around 15 per cent of us will have glaucoma. By using gene therapy, University of Melbourne ophthalmology professor, Keith Martin, and his team are aiming to encourage the cells that connect the eye to the brain to make new photoreceptors that pick up light, replacing those that have been lost. "The cells I'm most interested in glaucoma are called retinal ganglion cells and these are the cells that connect the eye to the brain," says Professor Martin. "When light hits the eye, photoreceptors pick up that light and they signal through to these retinal ganglion cells that send the messages back to our brain. If we lose that cable that connects the eye to the brain, the picture quality degrades." These days, if glaucoma is identified early - it can be effectively treated in most cases. But Professor Martin's research goes a step further. "We're moving beyond the era where all we could do for this chronic degenerative disease was slow things down, and we're now really talking about restoring function in a realistic way." Episode recorded: April 10, 2019. Interviewer: Dr Andi Horvath. Producer, audio engineer and editor: Chris Hatzis. Co-producers: Silvi Vann-Wall and Dr Andi Horvath. Banner image: Shutterstock.

Om Podcasten

Overhear researchers talk about what they do and why they do it. Hear them obsess, confess and profess - changing the world one experiment, one paper and one interview at a time. Listen in as seasoned eavesdropper Chris Hatzis follows reporters Dr Andi Horvath and Steve Grimwade on their meetings with magnificent minds. Made possible by the University of Melbourne.